创伤中NETosis的蛋白质组学分析:serpinB1作为关键因子的出现
该研究为COMBAT随机临床试验的事后分析,纳入单一一级创伤中心收治的创伤患者,采用靶向液相色谱-质谱联用进行蛋白质组学分析。结果显示,急诊科到达时serpinB1水平与NETosis蛋白质组标志物(核心组蛋白、转酮醇酶、S100A8/A9蛋白)显著相关;伤情更重者及非存活者、无 ventilator-free 和 ICU-free 天数更少者,急诊到达时serpinB1及主要NETosis标志物水平显著升高。全蛋白质组ROC分析中,serpinB1始终是与不良结局相关的最强蛋白之一;在NETosis标志物中,serpinB1在病程早期的水平对无 ventilator-free 和 ICU-free 天数少与多的患者区分度最大。基因本体分析支持NETosis可能是伤后器官功能障碍的介导因素。
要点
- 严重创伤患者急诊到达时serpinB1水平与NETosis蛋白质组标志物(核心组蛋白、转酮醇酶、S100A8/A9蛋白)显著相关。
- 伤情更重者急诊到达时serpinB1及NETosis标志物升高;非存活者和无 ventilator-free 及 ICU-free 天数更少者同样显著升高。
- 全蛋白质组ROC分析中serpinB1始终是与不良结局相关的最强蛋白之一。
- 在NETosis标志物中,serpinB1病程早期水平对无 ventilator-free 和 ICU-free 天数少与多的患者区分度最大。
- 基因本体分析支持NETosis可能是伤后器官功能障碍的潜在介导因素。
适用人群与场景
- COMBAT随机临床试验数据的事后分析,纳入单一一级创伤中心收治的创伤患者。
研究设计与关键结果
- 研究类型:COMBAT随机临床试验的事后分析;样本量原文未报告;单一一级创伤中心;人群为创伤患者;采用靶向液相色谱-质谱联用进行蛋白质组学分析。
- 急诊科到达时serpinB1水平与NETosis蛋白质组标志物(核心组蛋白、转酮醇酶、S100A8/A9蛋白)显著相关。
- 伤情更重的患者急诊到达时serpinB1和NETosis标志物升高。
- 非存活者及无 ventilator-free 和 ICU-free 天数更少的患者,急诊到达时serpinB1和主要NETosis标志物水平显著升高。
- 全蛋白质组ROC分析中,serpinB1始终是与不良结局相关的最强蛋白之一。
- 在NETosis标志物中,serpinB1在病程早期的水平对无 ventilator-free 和 ICU-free 天数少与多的患者区分度最大。
- 对不良结局最强预测因子的基因本体分析进一步支持NETosis是伤后器官功能障碍的潜在介导因素。
证据类型、等级与局限
- 证据类型:随机临床试验(COMBAT)的事后分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论指出,已识别创伤诱导NETosis的蛋白质组特征,NETosis是严重创伤后的早期过程,可能介导器官功能障碍。
- 原文结论指出,serpinB1是该NET蛋白质谱的主要成分,可能作为伤后过度NETosis的早期标志物。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Release of neutrophil extracellular traps (NETosis) may mediate postinjury organ dysfunction, but mechanisms remain unclear. The intracellular serine protease inhibitor (serpin) B1 is vital to neutrophil function and has been shown to restrict NETosis in inflammatory settings. In this study, we used discovery proteomics to identify the proteomic signature of trauma-induced NETosis. We hypothesized that serpinB1 would be a major component of this NET protein profile and associated with adverse outcomes.
METHODS: This was a post hoc analysis of data collected as part of the COMBAT randomized clinical trial. Blood was collected from injured patients at a single Level I Trauma Center. Proteomic analyses were performed through targeted liquid chromatography coupled with mass spectrometry. Abundances of serpinB1 and known NETosis markers were analyzed with patient and injury characteristics, clinical data, and outcomes.
RESULTS: SerpinB1 levels on emergency department (ED) arrival were significantly correlated with proteomic markers of NETosis, including core histones, transketolase, and S100A8/A9 proteins. More severely injured patients had elevated serpinB1 and NETosis markers on ED arrival. Levels of serpinB1 and top NETosis markers were significantly elevated on ED arrival in nonsurvivors and patients with fewer ventilator- and ICU-free days. In proteome-wide receiver operating characteristic analysis, serpinB1 was consistently among the top proteins associated with adverse outcomes. Among NETosis markers, levels of serpinB1 early in the patient's course exhibited the greatest separation between patients with fewer and greater ventilator- and ICU-free days. Gene Ontology analysis of top predictors of adverse outcomes further supports NETosis as a potential mediator of postinjury organ dysfunction.
CONCLUSION: We have identified a proteomic signature of trauma-induced NETosis, and NETosis is an early process following severe injury that may mediate organ dysfunction. In addition, serpinB1 is a major component of this NET protein profile that may serve as an early marker of excessive NETosis after injury.
参考来源
- Schaid TR, LaCroix I, Hansen KC, et al. A proteomic analysis of NETosis in trauma: Emergence of serpinB1 as a key player. J Trauma Acute Care Surg. 2022. PMID: 36730076. doi:10.1097/TA.0000000000003849
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。